EdgarLookup

ALNYLAM PHARMACEUTICALS, INC. — 10-Q Filings

65 10-Q filings on record

This page lists all 10-Q filings submitted to the SEC by ALNYLAM PHARMACEUTICALS, INC. (ALNY), sorted by most recent first. Each row links to the full filing on EdgarLookup. ALNYLAM PHARMACEUTICALS, INC. has filed 65 10-Q documents with the SEC since 2014. To view all SEC filings by ALNYLAM PHARMACEUTICALS, INC., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-Q 10-Q/A 144 15-12B 25 3 3/A 4 4/A 424B4 424B5 5 8-A12B 8-A12G 8-A12G/A 8-K ARS CORRESP CT ORDER DEF 14A DEFA14A EFFECT FWP PRE 14A PRER14A REGDEX REGDEX/A S-1 S-1/A S-3 S-3/A S-3ASR S-3MEF S-8 S-8 POS SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
10-Q ALNYLAM PHARMACEUTICALS, INC. 0000950135-09-003728 May 8, 2009 Mar 31, 2009
10-Q ALNYLAM PHARMACEUTICALS, INC. 0000950135-08-007045 Nov 7, 2008 Sep 30, 2008
10-Q ALNYLAM PHARMACEUTICALS, INC. 0000950135-08-005476 Aug 8, 2008 Jun 30, 2008
10-Q ALNYLAM PHARMACEUTICALS, INC. FORM 10-Q 0000950135-08-003576 May 9, 2008 Mar 31, 2008
10-Q ALNYLAM PHARMACEUTICALS, INC. FORM 10-Q 0000950135-07-006855 Nov 8, 2007 Sep 30, 2007
10-Q ALNYLAM PHARMACEUTICALS, INC. 0000950135-07-004883 Aug 9, 2007 Jun 30, 2007
10-Q ALNYLAM PHARMACEUTICALS, INC. 10-Q 0000950135-07-003049 May 10, 2007 Mar 31, 2007
10-Q ALNYLAM PHARMACEUTICALS, INC. 0000950135-06-006831 Nov 9, 2006 Sep 30, 2006
10-Q ALNYLAM PHARMACEUTICALS, INC. 0000950135-06-004794 Aug 4, 2006 Jun 30, 2006
10-Q ALNYLAM PHARMACEUTICALS, INC. 0000950135-06-003323 May 9, 2006 Mar 31, 2006
10-Q ALNYLAM PHARMACEUTICALS, INC. 0000950135-05-006490 Nov 14, 2005 Sep 30, 2005
10-Q ALNYLAM PHARMACEUTICALS, INC. 0000950135-05-004675 Aug 11, 2005 Jun 30, 2005
10-Q ALNYLAM PHARMACEUTICALS, INC. FORM 10-Q 0000950135-05-002883 May 16, 2005 Mar 31, 2005
10-Q ALNYLAM PHARMACEUTICALS, INC. 0000950135-04-005379 Nov 15, 2004 Sep 30, 2004
10-Q FORM 10-Q DATED 6/30/04 0000950135-04-003965 Aug 12, 2004 Jun 30, 2004